Krishnan Mahesh

Track

Insider profile

Krishnan Mahesh's trades of Halozyme Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
373.63
Quantity 40,195
Value US$3,611,235
Transaction date
Planned sale
Price
281.56
Quantity 92,999 -23.6%
Value US$3,208,337
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-30 2026-06-29
PlS Planned sale
15,772 +35.7%
318.94
US$4,656,145 		15,772 +35.7% 318.94 US$4,656,145
2026-06-29 2026-06-29
PrS Proposed sale
40,195
373.63
US$3,611,235 		40,195 373.63 US$3,611,235
2023-04-04 2023-04-04
PlS Planned sale
92,999 -23.6%
281.56
US$3,208,337 		92,999 -23.6% 281.56 US$3,208,337